Kathleen Neuzil
#126,139
Most Influential Person Now
American medical researcher
Kathleen Neuzil's AcademicInfluence.com Rankings
Kathleen Neuzillaw Degrees
Law
#2329
World Rank
#2906
Historical Rank
#1078
USA Rank
Common Law
#85
World Rank
#93
Historical Rank
#18
USA Rank
Download Badge
Law
Kathleen Neuzil's Degrees
- Masters Public Health University of Washington
Why Is Kathleen Neuzil Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kathleen Maletic Neuzil is the Director of the Center for Vaccine Development at the University of Maryland School of Medicine. She was elected to the National Academy of Medicine in 2019. Early life and education Neuzil studied zoology at the University of Maryland, College Park and graduated summa cum laude in 1983. She was a medical student at Johns Hopkins University, where she was a member of Alpha Omega Alpha. She completed her residency at Vanderbilt University, where she specialised in internal medicine in 1987. She was made a Fellow in infectious disease at Vanderbilt University in 1991. After completing her fellowship, Neuzil started a Master of public health and graduated in 1998.
Kathleen Neuzil's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (2020) (5634)
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) (2366)
- A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. (2005) (1780)
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates (2020) (1707)
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 (2021) (1283)
- The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. (2000) (1118)
- Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2020) (1069)
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020) (1020)
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial (2010) (739)
- Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. (1998) (730)
- Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. (2009) (666)
- Effectiveness of pneumococcal polysaccharide vaccine in older adults. (2003) (633)
- Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination (2020) (613)
- Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial (2010) (547)
- Effect of human rotavirus vaccine on severe diarrhea in African infants. (2010) (505)
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 (2021) (505)
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial (2021) (501)
- Evidence of bias in estimates of influenza vaccine effectiveness in seniors. (2006) (467)
- Influenza vaccination of pregnant women and protection of their infants. (2014) (443)
- Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. (2002) (421)
- The Burden of Community-Acquired Pneumonia in Seniors: Results of a Population-Based Study (2004) (413)
- The burden of influenza illness in children with asthma and other chronic medical conditions. (2000) (406)
- Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. (1993) (398)
- Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. (2002) (343)
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (322)
- Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine (2021) (308)
- Effectiveness of school-based influenza vaccination. (2006) (290)
- Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase (2021) (278)
- Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. (2006) (275)
- Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. (2003) (270)
- Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience (2001) (259)
- Homologous and Heterologous Covid-19 Booster Vaccinations (2022) (241)
- Influenza-associated morbidity and mortality in young and middle-aged women. (1999) (240)
- The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States (2021) (215)
- Safety of immunization during pregnancy: a review of the evidence of selected inactivated and live attenuated vaccines. (2014) (185)
- Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. (2006) (180)
- The impact of vaccination on COVID-19 outbreaks in the United States (2020) (169)
- Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study (2008) (169)
- Monitoring Influenza Activity in the United States: A Comparison of Traditional Surveillance Systems with Google Flu Trends (2011) (153)
- Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico (2021) (151)
- Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial (2021) (144)
- RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study (2020) (140)
- Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report (2020) (126)
- Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial (2012) (126)
- Effect of human rotavirus vaccine on severe diarrhea in African infants. (2010) (121)
- Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. (2012) (120)
- Safety of Herpes Zoster Vaccine in the Shingles Prevention Study (2010) (115)
- Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. (2002) (114)
- A Comparison of 2 Influenza Vaccine Schedules in 6- to 23-Month-Old Children (2005) (113)
- Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. (2009) (111)
- An economic analysis of annual influenza vaccination of children. (2005) (104)
- Global impact of rotavirus vaccines (2010) (102)
- Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. (2007) (102)
- Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal. (2019) (96)
- Immunization With Trivalent Inactivated Influenza Vaccine in Partially Immunized Toddlers (2006) (94)
- Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. (2012) (94)
- Influenza Vaccine Immunogenicity in 6- to 23-Month-Old Children: Are Identical Antigens Necessary for Priming? (2005) (93)
- A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response. (2014) (91)
- The safety of inactivated influenza vaccine adults and children with asthma. (2002) (91)
- Heterologous SARS-CoV-2 Booster Vaccinations – Preliminary Report (2021) (86)
- Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals. (2008) (85)
- Immunogenicity and reactogenicity of alternative schedules of HPV vaccine in Vietnam: a cluster randomized noninferiority trial. (2011) (84)
- Safety and immunogenicity of adjuvanted and unadjuvanted subunit influenza vaccines administered intranasally to healthy adults. (2000) (84)
- Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S (2022) (83)
- Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine. (1997) (83)
- Cardiopulmonary Hospitalizations During Influenza Season in Adults and Adolescents With Advanced HIV Infection (2003) (80)
- Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. (2011) (78)
- Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials (2020) (77)
- Influenza-associated cystic fibrosis pulmonary exacerbations. (2010) (75)
- Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. (2012) (71)
- Progress toward a Respiratory Syncytial Virus Vaccine (2016) (69)
- Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models. (2020) (68)
- The Association of Sociodemographic Factors and Patient Attitudes on Influenza Vaccination Rates in Older Persons (2004) (67)
- The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV[INCREMENT]G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak (2018) (64)
- The Burden of Influenza-Associated Critical Illness Hospitalizations* (2014) (62)
- Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative study. (2003) (61)
- Serum vitamin A levels in respiratory syncytial virus infection. (1994) (61)
- Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection (2020) (61)
- Efficacy of the oral pentavalent rotavirus vaccine in Mali. (2012) (60)
- Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial (2017) (58)
- Burden of community-onset Escherichia coli bacteremia in seniors. (2005) (58)
- Immunogenicity of the pentavalent rotavirus vaccine in African infants. (2012) (57)
- Protective Role of TNF-alpha in respiratory syncytial virus infection in vitro and in vivo. (1996) (57)
- Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. (2010) (56)
- Recommended adult immunization schedule: United States, October 2007-September 2008 (2007) (55)
- Compliance With the Recommendations for 2 Doses of Trivalent Inactivated Influenza Vaccine in Children Less Than 9 Years of Age Receiving Influenza Vaccine for the First Time: A Vaccine Safety Datalink Study (2006) (54)
- Winter respiratory viruses and health care use: a population-based study in the northwest United States. (2003) (53)
- Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine (2014) (53)
- Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial (2016) (52)
- Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant (2022) (51)
- Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial (2017) (50)
- Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study. (2018) (50)
- Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine. (2003) (50)
- Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016 (2018) (50)
- Safety of zoster vaccine in elderly adults following documented herpes zoster. (2013) (49)
- Rotavirus vaccination and intussusception – Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries (2016) (49)
- Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine. (2005) (47)
- Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial (2016) (46)
- Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. (2008) (45)
- Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis (2013) (44)
- Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial (2016) (43)
- Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya. (2012) (43)
- Influenza and Pneumococcal Vaccination in Older Veterans: Results from the Behavioral Risk Factor Surveillance System (2006) (42)
- Estimating the full public health value of vaccination. (2017) (41)
- Immunogenicity of quadrivalent HPV vaccine among girls 11 to 13 Years of age vaccinated using alternative dosing schedules: results 29 to 32 months after third dose. (2013) (41)
- Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. (2006) (40)
- Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study (2019) (39)
- Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study (2017) (39)
- Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design (2017) (38)
- Data and product needs for influenza immunization programs in low- and middle-income countries: Rationale and main conclusions of the WHO preferred product characteristics for next-generation influenza vaccines. (2017) (38)
- Efficacy of Typhoid Conjugate Vaccine in Nepal: An Interim Analysis of a Participant-and Observer-Blinded Randomized Phase III Trial (2019) (38)
- Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009. (2013) (38)
- Persistence of Campylobacter fetus bacteremia associated with absence of opsonizing antibodies (1994) (38)
- A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands. (2019) (38)
- Outpatient upper respiratory tract viral infections in children with malaria symptoms in Western Kenya. (2010) (37)
- COVID-19 vaccine strategies must focus on severe disease and global equity (2021) (37)
- Protective Role of TNF-α in Respiratory Syncytial Virus Infection In Vitro and In Vivo (1996) (36)
- Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa. (2012) (36)
- Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? (2010) (34)
- Expanding the Recommendations for Annual Influenza Vaccination to School-Age Children in the United States (2012) (34)
- Influenza Immunization in Low- and Middle-Income Countries: Preparing for Next-Generation Influenza Vaccines. (2019) (34)
- Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial (2021) (33)
- Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population. (2006) (33)
- Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children (2021) (31)
- Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam. (2012) (29)
- Characteristics and Outcomes of Older Adults with Community‐Acquired Pneumococcal Bacteremia (2006) (29)
- Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium (2013) (29)
- Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France). (2013) (29)
- Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation. (2009) (28)
- Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge (2021) (28)
- Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity (2022) (27)
- Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants. (2012) (26)
- Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines (2021) (25)
- Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. (2012) (25)
- Influenza vaccine: issues and opportunities. (2001) (25)
- Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial (2022) (25)
- Traditional cooking practices and preferences for stove features among women in rural Senegal: Informing improved cookstove design and interventions (2018) (24)
- Safety of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled clinical trial among children in urban Bangladesh. (2015) (24)
- Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus. (1997) (23)
- Future epidemiological and economic impacts of universal influenza vaccines (2019) (23)
- Influenza vaccines in children. (2002) (23)
- Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia. (2012) (23)
- The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children (2018) (22)
- 2009 influenza A(H1N1) monovalent vaccines for children. (2010) (22)
- WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008. (2009) (22)
- Typhoid Vaccine Acceleration Consortium Malawi: A Phase III, Randomized, Double-blind, Controlled Trial of the Clinical Efficacy of Typhoid Conjugate Vaccine Among Children in Blantyre, Malawi (2019) (22)
- Efficacy, duration of protection, birth outcomes, and infant growth associated with influenza vaccination in pregnancy: a pooled analysis of three randomised controlled trials (2020) (22)
- Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants (2018) (21)
- Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi. (2012) (21)
- Executive summary--Actions to strengthen adult and adolescent immunization coverage in the United States: policy principles of the Infectious Diseases Society of America. (2007) (21)
- Annual universal influenza vaccination: ready or not? (2006) (21)
- Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review (2017) (21)
- Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh. (2012) (21)
- Cytokine release and innate immunity in respiratory viral infection (1996) (20)
- Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial (2021) (20)
- National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines (2021) (19)
- Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2021) (19)
- Influenza Pneumonia Surveillance among Hospitalized Adults May Underestimate the Burden of Severe Influenza Disease (2014) (19)
- Influenza vaccine in children with asthma: why no progress? (2001) (19)
- Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh (2018) (18)
- Interplay between Emerging SARS-CoV-2 Variants and Pandemic Control. (2021) (18)
- Pandemic influenza vaccine policy--considering the early evidence. (2009) (18)
- Influenza immunization of pregnant women in resource-constrained countries: an update for funding and implementation decisions (2017) (17)
- Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial (2022) (17)
- Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016. (2018) (17)
- A proposed framework for evaluating and comparing efficacy estimates in clinical trials of new rotavirus vaccines. (2014) (16)
- Predictors of influenza vaccination in the Cystic Fibrosis Foundation patient registry, 2006 through 2007. (2010) (16)
- Influenza vaccine manufacture: keeping up with change. (2009) (16)
- Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka. (2014) (15)
- Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial (2019) (15)
- Effectiveness of seasonal influenza vaccination of children in Senegal during a year of vaccine mismatch: a cluster-randomized trial. (2019) (15)
- Influenza: A Global Perspective. (2017) (15)
- Implementation of maternal influenza immunization in El Salvador: Experiences and lessons learned from a mixed-methods study. (2018) (14)
- Rotavirus in Africa: shifting the focus to disease prevention. (2010) (14)
- Forecasting demand for maternal influenza immunization in low- and lower-middle-income countries (2018) (14)
- Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge (2021) (14)
- Background Paper on Influenza Vaccines and Immunization Background Paper on Influenza Vaccines and Immunization Sage Working Group Executive Summary Findings and Recommendations Background Paper on Influenza Vaccines and Immunization Background Paper on Influenza Vaccines and Immunization I. Context (14)
- Introduction of Typhoid Conjugate Vaccines in Africa and Asia (2019) (13)
- Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial (2022) (13)
- Influenza vaccine for young children: two doses are better than one. (2006) (13)
- Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials (2020) (13)
- Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial (2022) (13)
- Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections (1995) (13)
- SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses (2022) (13)
- Neurologic Manifestations of Human Monocytic Ehrlichiosis (1998) (12)
- Morbidity and Mortality of Typhoid Intestinal Perforation Among Children in Sub-Saharan Africa 1995–2019: A Scoping Review (2020) (12)
- Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials (2017) (12)
- Maternal immunization in Malawi: A mixed methods study of community perceptions, programmatic considerations, and recommendations for future planning (2019) (12)
- Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-naïve children in a randomized clinical trial in rural Senegal. (2018) (11)
- Influenza: New insights into an old disease (2000) (11)
- Estimating pediatric asthma prevalence in rural senegal: A cross‐sectional survey (2017) (11)
- Community-acquired diarrhoea in a world with rotavirus vaccine: a glimpse into the future. (2015) (11)
- Immunogenicity, efficacy of inactivated/live virus seasonal and pandemic vaccines (2013) (11)
- Effective Immunization of Older Adults Against Seasonal Influenza. (2018) (11)
- A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated (2021) (11)
- How Can We Solve the Enigma of Influenza Vaccine–Induced Protection? (2014) (10)
- Maternal influenza immunization in Malawi: Piloting a maternal influenza immunization program costing tool by examining a prospective program (2017) (10)
- Anti-nucleocapsid antibodies following SARS-CoV-2 infection in the blinded phase of the mRNA-1273 Covid-19 vaccine efficacy clinical trial (2022) (10)
- Preventing Shingles and Its Complications in Older Persons. (2016) (10)
- Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives? (2019) (10)
- The Vaccine Handbook: A Practical Guide for Clinicians (2004) (10)
- A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model (2021) (10)
- The global implications of influenza in Hong Kong. (2002) (10)
- A Description of the Statistical Methods for the Vaccine Impact on Diarrhea in Africa (VIDA) Study (2023) (10)
- Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso (2020) (9)
- Corrigendum to “Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants” [Vaccine 26 (2008) 2234–2241] (2014) (9)
- Impact of Rotavirus Vaccine Introduction in Children Less Than 2 Years of Age Presenting for Medical Care With Diarrhea in Rural Matlab, Bangladesh (2019) (9)
- The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality (2022) (8)
- Vaccine safety--achieving the proper balance. (2005) (8)
- Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study (2022) (8)
- Pharmacologic Therapy for Human Immunodeficiency Virus Infection: A Review (1994) (8)
- Effects of Air Pollution and Other Environmental Exposures on Estimates of Severe Influenza Illness, Washington, USA (2020) (8)
- Does Google Influenza Tracking Correlate With Laboratory Tests Positive For Influenza (2010) (8)
- WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use (2022) (8)
- Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt? (2009) (8)
- A Phase II, Randomized, Double-blind, Controlled Safety and Immunogenicity Trial of Typhoid Conjugate Vaccine in Children Under 2 Years of Age in Ouagadougou, Burkina Faso: A Methods Paper (2019) (8)
- Forecasting Demand for the Typhoid Conjugate Vaccine in Low- and Middle-income Countries (2019) (8)
- Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial (2021) (8)
- Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions (2021) (7)
- Shin, S. et al. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam. Vaccine 30 (Suppl 1), A106-A113 (2012) (7)
- Annual studies of influenza vaccine effectiveness: evaluating performance, informing policy, and generating new questions. (2014) (7)
- Evolution of the Pediatric Influenza Vaccination Program in the United States (2012) (7)
- Influenza vaccine for children. (2004) (7)
- The operational impact of deploying SARS-CoV-2 vaccines in countries of the WHO African Region (2020) (7)
- Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months (2022) (7)
- PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries (2012) (7)
- Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial (2020) (7)
- Infl uenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people : a population-based , nested case-control study (2008) (6)
- Influenza vaccination in 2013-2014: achieving 100% participation. (2013) (6)
- The Time is Now to Control Typhoid (2019) (6)
- The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region (2021) (6)
- Which Countries Have Adult Vaccine Programs? A Global Review of National Adult Influenza and Pneumococcal Vaccine Policies (2020) (6)
- Estimates of inactivated influenza vaccine effectiveness among children in Senegal: results from two consecutive cluster-randomized controlled trials in 2010 and 2011. (2020) (6)
- Networks of face-to-face social contacts in Niakhar, Senegal (2019) (5)
- Prospects of Future Typhoid and Paratyphoid Vaccines in Endemic Countries (2021) (5)
- Influenza Vaccines and Vaccination Strategies (2016) (5)
- Peripherally inserted central catheter (PICC) bloodstream infection surveillance rates in medical intensive care, medical-surgical wards, extended care, and outpatients (2005) (5)
- Rotavirus vaccines for children in developing countries: understanding the science, maximizing the impact, and sustaining the effort. (2012) (5)
- Extrapulmonary thoracic disease caused by Blastomyces dermatitidis. (1994) (5)
- Serological Evidence of Ebola Virus Infection in Rural Guinea before the 2014 West African Epidemic Outbreak. (2018) (5)
- Influenza Vaccination Rates of Children in Households with High-Risk Adults (2010) (4)
- Influenza vaccine programs for children in low- and middle-income countries: current status and way forward (2019) (4)
- The value of vaccine programme impact monitoring during the COVID-19 pandemic (2021) (4)
- Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA) Using a Cluster-Randomized Controlled Phase IV Trial: Trial Design and Population Baseline Characteristics (2021) (4)
- Trivalent influenza vaccination randomized control trial of pregnant women and adverse fetal outcomes (2019) (4)
- SARS-CoV-2 Omicron Neutralization After Heterologous Vaccine Boosting (2022) (4)
- Typhoid conjugate vaccine in Africa and Asia: Status of clinical evaluation and vaccine introduction. (2021) (4)
- Reaching every child with rotavirus vaccine: Report from the 10th African rotavirus symposium held in Bamako, Mali (2017) (4)
- The promise of maternal vaccination to prevent influenza in young infants. (2011) (3)
- Lack of Efficacy of Trivalent Influenza Vaccination of HIV-Negative Pregnant Women Against Adverse Fetal Outcomes: A Randomized Clinical Trial (2015) (3)
- Typhoid Conjugate Vaccines: Advancing the Research and Public Health Agendas (2021) (3)
- Vitamin A therapy for respiratory syncytial virus infection. (1997) (3)
- Primary hepatic actinomycosis--diagnosis by percutaneous transhepatic needle aspiration. (1993) (3)
- Influenza vaccines: more options and more opportunities. (2012) (3)
- National Routine Adult Immunization Programs among World Health Organization Member States: An Assessment of Health Systems to Deploy Future SARS-CoV-2 Vaccines (2020) (3)
- Where high-risk adults receive influenza vaccine during a shortage. (2007) (3)
- Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. Commentary (2006) (2)
- Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial (2022) (2)
- Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine – An Interim Analysis (2022) (2)
- COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004) (2022) (2)
- Early Insights From Clinical Trials of Typhoid Conjugate Vaccine (2020) (2)
- Influenza Among Young Children in Bangladesh: Clinical Characteristics and Outcomes From a Randomized Clinical Trial (2017) (2)
- Seroepidemiology of pertussis in senior adults. (2001) (2)
- Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial (2020) (2)
- Efficacy and immunogenicity of inactivated influenza vaccine in pregnant women: A randomized, double-blind, placebo controlled trial (2014) (2)
- Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2021) (2)
- Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam. (2018) (2)
- Randomized, placebo-controlled trial on safety and efficacy of inactivated influenza vaccination of pregnant women in preventing illness in their infants (2014) (2)
- Influenza Vaccines for Older Persons: Progress and Pitfalls. (2017) (1)
- Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trials. (2022) (1)
- Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocol (2022) (1)
- Benefit of 2 Doses of Influenza Vaccine in Vaccine-Naïve Children 5-8 Years Old (2005) (1)
- Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial (2023) (1)
- LB6. Asymptomatic Infection and Duration of Viral Shedding in Symptomatic Breakthrough Infections in a Phase 3 Study of AZD1222 (ChAdOx1 nCoV-19) (2021) (1)
- Trajectory of viral load in a prospective population-based cohort with incident SARS-CoV-2 G614 infection (2021) (1)
- Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. (2023) (1)
- Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition Is Associated With Individual Exposure but Not Community-Level Transmission (2022) (1)
- LB-17. Efficacy of Hydroxychloroquine (HCQ) for Post-exposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Blinded, Randomized, Controlled Trial (2020) (1)
- Infection control risk reduction strategies through rapid and effective two-way electronic communication (2005) (1)
- Prevalence of Salmonella in Stool During the Vaccine Impact on Diarrhea in Africa (VIDA) Study, 2015–2018 (2023) (1)
- Hemarthrosis and oral anticoagulants. (1991) (1)
- Management of Diarrhea in Young Children in Sub-Saharan Africa: Adherence to World Health Organization Recommendations During the Global Enteric Multisite Study (2007–2011) and the Vaccine Impact of Diarrhea in Africa (VIDA) Study (2015–2018) (2023) (1)
- Safety and Immunogenicity of Co-Administration of Meningococcal Type A and Measles Rubella Vaccines with Typhoid Conjugate Vaccine in Children Aged 15-23 Months in Burkina Faso (2020) (1)
- The Art and Science of Delivering Influenza Vaccines. (2016) (1)
- Detection and Kinetics of Subgenomic Severe Acute Respiratory Syndrome Coronavirus 2 RNA Viral Load in Longitudinal Diagnostic RNA–Positive Samples (2022) (1)
- Population-Based Incidence Of Influenza-Associated Respiratory Failure Hospitalizations In The US West Coast, 2003 To 2008 (2012) (1)
- How do we best prevent influenza in young children? (2018) (1)
- A case of noncardiogenic pulmonary edema. (1991) (1)
- The Operational Feasibility of Vaccination Programs Targeting Influenza Risk Groups in the World Health Organization (WHO) African and South-East Asian Regions (2021) (1)
- Understanding COVID-19 through human challenge models (2022) (1)
- Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial. (2020) (1)
- Phosphorus-Related Mechanisms of Vascular Calcification (2017) (1)
- Histo-Blood Group Antigen Null Phenotypes Associated With a Decreased Risk of Clinical Rotavirus Vaccine Failure Among Children <2 Years of Age Participating in the Vaccine Impact on Diarrhea in Africa (VIDA) Study in Kenya, Mali, and the Gambia (2023) (0)
- Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence (2023) (0)
- Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine (2003) (0)
- Audio Interview: Developing New Covid-19 Vaccines. (2022) (0)
- Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data (2022) (0)
- Stiff neck and fever in a nursing home patient. (1991) (0)
- Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis (2022) (0)
- Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial (2022) (0)
- New Vaccine Strategies (2009) (0)
- Safety and immunogenicity of monovalent H7N9 influenza vaccine with AS03 adjuvant given sequentially or simultaneously with a seasonal influenza vaccine: A randomized clinical trial. (2022) (0)
- A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy Adults (2022) (0)
- A toxic cause of chest pain. (1991) (0)
- Prevalence, Clinical Severity, and Seasonality of Adenovirus 40/41, Astrovirus, Sapovirus, and Rotavirus Among Young Children With Moderate-to-Severe Diarrhea: Results From the Vaccine Impact on Diarrhea in Africa (VIDA) Study (2023) (0)
- A case of secondary hypertension. (1991) (0)
- Reply to Skowronski and De Serres. (2019) (0)
- Enteric Fever - Tools for Prevention. (2023) (0)
- Commentary: Quantifying the Impact of Maternal Influenza Vaccination-Beyond Laboratory-Confirmed Efficacy. (2018) (0)
- 95 CHARACTERISTICS AND OUTCOMES OF OLDER ADULTS WITH COMMUNITY-ACQUIRED PNEUMOCOCCAL BACTEREMIA (2004) (0)
- Typhoid Conjugate Vaccine Trial in Nepal: A Phase III Efficacy Analysis (2019) (0)
- Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults (2020) (0)
- An mRNA Influenza Vaccine - Could It Deliver? (2023) (0)
- Reply to: Vitamin A for varicella (1994) (0)
- Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses. (2023) (0)
- Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine (2023) (0)
- Self-Assessed Severity as a Determinant of Coronavirus Disease 2019 Symptom Specificity: A Longitudinal Cohort Study (2022) (0)
- Book Review State of Immunity: The Politics of Vaccination in Twentieth-Century America (California/Milbank Books on Health and the Public. 16.) By James Colgrove. 332 pp., illustrated. Berkeley, University of California Press, 2006. $39.95. 978-0-520-24749-9 (2007) (0)
- 486. A/California/07/2009-pdm-like (H1N1) Influenza Virus Controlled Human Infection Model (CHIM) Activates Various Immune Cells Despite Induction of Mild Symptomatology (2022) (0)
- Estimating the Impact of Vaccination on Antimicrobial-Resistant Typhoid Fever in Gavi-73 Countries (2021) (0)
- Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial. (2021) (0)
- Reducing the Risk of Postoperative Eye Infections (2004) (0)
- Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial (2022) (0)
- The authors reply. (2015) (0)
- omparison of two clinical severity scoring systems in two multi-center , eveloping country rotavirus vaccine trials in Africa and Asia (2012) (0)
- Chapter 21 Influenza Vaccines and Vaccination Strategies (2016) (0)
- ImmunogenicityandReactogenicityofAlternative Schedules of HPV Vaccine in Vietnam (2017) (0)
- Abdominal pain in a Kuwaiti woman. (1992) (0)
- Prevention and Control of Coronavirus Disease 2019: Where Do We Go From Here? (2022) (0)
- Contributors (2008) (0)
- Upper extremity vaso-occlusive disease in a patient with giant cell arteritis. (1991) (0)
- Influenza- and Respiratory Syncytial Virus-Related Morbidity in Chronic Lung Disease (2016) (0)
- A woman with nausea, vomiting, and renal failure. (1991) (0)
- Vaccines in Low Resource Settings: What is on the Horizon? (2014) (0)
- Controversies in Vaccinating Children: European and U.S. Perspectives (2008) (0)
- Rotavirus vaccine efficacy in African and Asian countries – Authors' reply (2010) (0)
- Using social contact data to improve the overall effect estimate of a cluster‐randomized influenza vaccination program in Senegal (2020) (0)
- Immunized Toddlers Immunization With Trivalent Inactivated Influenza Vaccine in Partially (2013) (0)
- econdary efficacy endpoints of the pentavalent rotavirus vaccine against astroenteritis in sub-Saharan Africa (2012) (0)
- Prolonged fever in a young woman. (1991) (0)
- Novel vaccine strategies to control influenza infections (2014) (0)
- Liaisons from Organizations (2010) (0)
- Using time‐weighted average change from baseline of SARS‐CoV‐2 viral load to assess impact of hydroxychloroquine as postexposure prophylaxis and early treatment for COVID‐19 (2022) (0)
- Developing mucosal vaccines for SARS-CoV-2: What will it take? (2022) (0)
- Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial (2023) (0)
- Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study (2023) (0)
- The Ghost of the Future: Universal Influenza Vaccine (2018) (0)
- Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. (2023) (0)
- The Impact of Influenza Vaccine: It's the Size of the Glass. (2019) (0)
This paper list is powered by the following services:
Other Resources About Kathleen Neuzil
What Schools Are Affiliated With Kathleen Neuzil?
Kathleen Neuzil is affiliated with the following schools:
